Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Pharmaceuticals company Torrent Pharmaceuticals announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue at Rs 2,959 crore; grew by 8% YoY. Gross Margin: 75.3%, Op. EBITDA margin at 32.6%. Op. EBITDA at Rs 964 crore, up by 9% YoY. Net Profit after tax at Rs 498 crore, up by 11% YoY. R&D; Spend was Rs 150 crore (5.1%) vs Rs 139 crore (5.1%) — up 8% YoY FY25 Financial Highlights: Revenue reached Rs 11,516 crore vs Rs 10,728 crore — up 7% YoY Gross Profit grew to Rs 8,740 crore (75.9%) from Rs 8,042 crore (75.0%) — up 9% YoY Operating EBITDA increased to Rs 3,721 crore (32.3%) from Rs 3,368 crore (31.4%) — up 10% YoY PAT (adjusted) came in at Rs 1,911 crore (16.6%) vs Rs 1,656 crore (15.4%) — up 15% YoY R&D; Spend rose to Rs 581 crore (5.0%) vs Rs 527 crore (4.9%) — up 10% YoY Result PDF